Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
380 participants
INTERVENTIONAL
2005-06-30
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bifeprunox
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Bipolar Disorder and must be experiencing a depressive episode.
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Solvay Pharmaceuticals
INDUSTRY
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor, MD
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Beverly Hills, California, United States
National City, California, United States
Stanford, California, United States
Farmington Hills, Connecticut, United States
Bradenton, Florida, United States
Jacksonville, Florida, United States
Orlando, Florida, United States
West Palm Beach, Florida, United States
Smyrna, Georgia, United States
Honolulu, Hawaii, United States
Terre Haute, Indiana, United States
Florence, Kentucky, United States
New Orleans, Louisiana, United States
Rockville, Maryland, United States
Boston, Massachusetts, United States
Farmington Hills, Michigan, United States
Saint Charles, Missouri, United States
Clementon, New Jersey, United States
Moorestown, New Jersey, United States
Lawrence, New York, United States
New York, New York, United States
New York, New York, United States
Staten Island, New York, United States
The Bronx, New York, United States
Winston-Salem, North Carolina, United States
Cincinnati, Ohio, United States
Dayton, Ohio, United States
Lyndhurst, Ohio, United States
Oklahoma City, Oklahoma, United States
Tulsa, Oklahoma, United States
Portland, Oregon, United States
Philadelphia, Pennsylvania, United States
Charleston, South Carolina, United States
Austin, Texas, United States
Dallas, Texas, United States
Salt Lake City, Utah, United States
Bellevue, Washington, United States
Seattle, Washington, United States
Brown Deer, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3168A2-307
Identifier Type: -
Identifier Source: org_study_id